» Articles » PMID: 38144461

Is Recovery Just the Beginning? Persistent Symptoms and Health and Performance Deterioration in Post-COVID-19, Non-hospitalized University Students-a Cross-sectional Study

Overview
Specialty Biology
Date 2023 Dec 25
PMID 38144461
Authors
Affiliations
Soon will be listed here.
Abstract

Many individuals experience persistent symptoms such as deteriorated physical and mental health, increased fatigue, and reduced cognitive performance months after recovering from coronavirus disease 2019 (COVID-19). There is limited data on the long-term trajectory and prevalence of these symptoms, especially in milder cases. Our study aimed to assess the persistent effects of COVID-19 on physical and mental health, fatigue, and cognitive performance in a cohort of 214 students, averaging 21.8 years of age. Of these, 148 had contracted COVID-19 but were not hospitalized, with the time since infection ranging from 1 to 39 months. We utilized a comprehensive panel of cognitive tests to measure intelligence, memory, and psychomotor skills, and a detailed anamnestic questionnaire to evaluate physical and mental health. While contracting COVID-19 did not significantly impact overall health and performance, it was associated with increased reports of fatigue. However, the reported severity of the disease had a pronounced negative influence on physical health, mental well-being, fatigue, and reaction time. Trends of improvement in physical and mental health, as well as error rate, were observed within the first 2 years post-infection. However, fatigue and reaction time showed a trend of deterioration. Beyond the 2-year mark, physical health and error rate continued to improve, while mental health began to deteriorate. Fatigue and reaction time continued to decline. Overall, our findings suggest that some effects of contracting COVID-19 can persist or even deteriorate over time, even in younger individuals who had mild cases that did not require hospitalization.

Citing Articles

Persistent Health and Cognitive Impairments up to Four Years Post-COVID-19 in Young Students: The Impact of Virus Variants and Vaccination Timing.

Latifi A, Flegr J Biomedicines. 2025; 13(1).

PMID: 39857653 PMC: 11760454. DOI: 10.3390/biomedicines13010069.


Long-term cognitive and autonomic effects of COVID-19 in young adults: a cross-sectional study at 28 months.

Gopinath G, Suryavanshi C, L C P Ann Med. 2025; 57(1):2453082.

PMID: 39819240 PMC: 11749284. DOI: 10.1080/07853890.2025.2453082.


Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.

Melillo A, Perrottelli A, Caporusso E, Coltorti A, Giordano G, Giuliani L Eur Psychiatry. 2024; 67(1):e60.

PMID: 39328154 PMC: 11457117. DOI: 10.1192/j.eurpsy.2024.1770.


COVID's long shadow: How SARS-CoV-2 infection, COVID-19 severity, and vaccination status affect long-term cognitive performance and health.

Flegr J, Latifi A Biol Methods Protoc. 2023; 8(1):bpad038.

PMID: 38130975 PMC: 10733723. DOI: 10.1093/biomethods/bpad038.

References
1.
Papazacharias A, Nardini M . The relationship between depression and cognitive deficits. Psychiatr Danub. 2012; 24 Suppl 1:S179-82. View

2.
Fernandez-de-Las-Penas C, de-la-Llave-Rincon A, Ortega-Santiago R, Ambite-Quesada S, Gomez-Mayordomo V, Cuadrado M . Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2021; 163(9):e989-e996. DOI: 10.1097/j.pain.0000000000002564. View

3.
Fumagalli C, Zocchi C, Tassetti L, Silverii M, Amato C, Livi L . Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. 2021; 97:36-41. PMC: 8648678. DOI: 10.1016/j.ejim.2021.11.018. View

4.
Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J . Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021; 46:39-48. PMC: 8006192. DOI: 10.1016/j.euroneuro.2021.03.019. View

5.
OMahoney L, Routen A, Gillies C, Ekezie W, Welford A, Zhang A . The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2022; 55:101762. PMC: 9714474. DOI: 10.1016/j.eclinm.2022.101762. View